Albemarle:
“In fact the company says it now expect “significant growth in full-year 2022 results including net sales of $US7.1 – $US7.5 billion,” or twice the 2021 figure.
Adjusted EBITDA for 2022 is now forecast to be three times the 2021 figure in a range of $US3.2 – $US3.5 billion.”
LIONTOWN: year 1 my projection
511,000 x (usd7,000-usd540AISC) = USD3.3 billion
I’m bullish the selling price could improve further significantly due to structural deficit. And along with huge Tantalum byproduct, Ltr will not sell substandard SC6, all products are battery grade, way above 6%, unlike pls and AKE whose spod is 5.4%, and AKE brine has only 45% of production meeting battery grade, 55% is below battery grade leading to battered selling price.
what’s the message?
Liontown, the next Albemarle. Simples
all imo
- Forums
- ASX - By Stock
- LTR
- Lithium Related Media Articles
Lithium Related Media Articles, page-12132
- There are more pages in this discussion • 10,158 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add LTR (ASX) to my watchlist
(20min delay)
|
|||||
Last
$1.23 |
Change
0.000(0.00%) |
Mkt cap ! $2.970B |
Open | High | Low | Value | Volume |
$1.23 | $1.24 | $1.20 | $6.000M | 4.926M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 20000 | $1.23 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.23 | 25711 | 4 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 20000 | 1.225 |
2 | 21559 | 1.220 |
3 | 23420 | 1.215 |
7 | 161354 | 1.210 |
1 | 33061 | 1.205 |
Price($) | Vol. | No. |
---|---|---|
1.230 | 25711 | 4 |
1.235 | 71382 | 5 |
1.240 | 37411 | 3 |
1.245 | 53629 | 3 |
1.250 | 6675 | 5 |
Last trade - 16.10pm 02/05/2024 (20 minute delay) ? |
|
|||||
Last
$1.22 |
  |
Change
0.000 ( 0.91 %) |
|||
Open | High | Low | Volume | ||
$1.24 | $1.24 | $1.20 | 1572354 | ||
Last updated 15.59pm 02/05/2024 ? |
Featured News
LTR (ASX) Chart |
The Watchlist
RDN
RAIDEN RESOURCES LIMITED
Dusko Ljubojevic, MD
Dusko Ljubojevic
MD
SPONSORED BY The Market Online